BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 1419645)

  • 1. Value of epidermal growth factor receptor status compared with growth fraction and other factors for prognosis in early breast cancer.
    Gasparini G; Bevilacqua P; Pozza F; Meli S; Boracchi P; Marubini E; Sainsbury JR
    Br J Cancer; 1992 Nov; 66(5):970-6. PubMed ID: 1419645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features.
    Gasparini G; Gullick WJ; Bevilacqua P; Sainsbury JR; Meli S; Boracchi P; Testolin A; La Malfa G; Pozza F
    J Clin Oncol; 1992 May; 10(5):686-95. PubMed ID: 1349034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multiparametric study on the prognostic value of epidermal growth factor receptor in operable breast carcinoma.
    Gasparini G; Boracchi P; Bevilacqua P; Mezzetti M; Pozza F; Weidner N
    Breast Cancer Res Treat; 1994 Jan; 29(1):59-71. PubMed ID: 7912568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell proliferation of breast cancer evaluated by anti-BrdU and anti-Ki-67 antibodies: its prognostic value on short-term recurrences.
    Gaglia P; Bernardi A; Venesio T; Caldarola B; Lauro D; Cappa AP; Calderini P; Liscia DS
    Eur J Cancer; 1993; 29A(11):1509-13. PubMed ID: 8217353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer.
    Tsutsui S; Ohno S; Murakami S; Hachitanda Y; Oda S
    Breast Cancer Res Treat; 2002 Jan; 71(1):67-75. PubMed ID: 11859875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer.
    Sainsbury JR; Farndon JR; Needham GK; Malcolm AJ; Harris AL
    Lancet; 1987 Jun; 1(8547):1398-402. PubMed ID: 2884496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of epidermal growth factor receptor expression in primary breast cancer: results of a biochemical study and an immunocytochemical study.
    Toi M; Tominaga T; Osaki A; Toge T
    Breast Cancer Res Treat; 1994 Jan; 29(1):51-8. PubMed ID: 7912567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor expression as a prognostic indicator in breast cancer.
    Toi M; Osaki A; Yamada H; Toge T
    Eur J Cancer; 1991; 27(8):977-80. PubMed ID: 1832907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients.
    Fox SB; Smith K; Hollyer J; Greenall M; Hastrich D; Harris AL
    Breast Cancer Res Treat; 1994 Jan; 29(1):41-9. PubMed ID: 8018963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup.
    Nicholson S; Richard J; Sainsbury C; Halcrow P; Kelly P; Angus B; Wright C; Henry J; Farndon JR; Harris AL
    Br J Cancer; 1991 Jan; 63(1):146-50. PubMed ID: 1846551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators.
    Travis A; Pinder SE; Robertson JF; Bell JA; Wencyk P; Gullick WJ; Nicholson RI; Poller DN; Blamey RW; Elston CW; Ellis IO
    Br J Cancer; 1996 Jul; 74(2):229-33. PubMed ID: 8688326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis.
    Pellikainen MJ; Pekola TT; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
    J Clin Pathol; 2003 Mar; 56(3):214-20. PubMed ID: 12610102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of epidermal growth factor receptor in breast carcinoma.
    Lewis S; Locker A; Todd JH; Bell JA; Nicholson R; Elston CW; Blamey RW; Ellis IO
    J Clin Pathol; 1990 May; 43(5):385-9. PubMed ID: 2370306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.
    Gasparini G; Pozza F; Meli S; Reitano M; Santini G; Bevilacqua P
    Anticancer Res; 1991; 11(6):2015-21. PubMed ID: 1776834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor angiogenesis in node-negative breast carcinomas--relationship with epidermal growth factor receptor, estrogen receptor, and survival.
    Fox SB; Leek RD; Smith K; Hollyer J; Greenall M; Harris AL
    Breast Cancer Res Treat; 1994 Jan; 29(1):109-16. PubMed ID: 7517221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
    Korkolopoulou P; Christodoulou P; Kouzelis K; Hadjiyannakis M; Priftis A; Stamoulis G; Seretis A; Thomas-Tsagli E
    Br J Cancer; 1997; 75(9):1269-78. PubMed ID: 9155045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor (EGFR) as a prognostic marker: an immunohistochemical study on 315 consecutive breast carcinoma patients.
    Aziz SA; Pervez S; Khan S; Kayani N; Rahbar MH
    J Pak Med Assoc; 2002 Mar; 52(3):104-10. PubMed ID: 12071064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptors in breast cancer: association with early relapse and death, poor response to hormones and interactions with neu.
    Harris AL; Nicholson S; Sainsbury JR; Farndon J; Wright C
    J Steroid Biochem; 1989; 34(1-6):123-31. PubMed ID: 2576295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor in breast cancer: correlation of quantitative immunocytochemical assays to prognostic factors.
    Charpin C; Devictor B; Bonnier P; Andrac L; Lavaut MN; Allasia C; Piana L
    Breast Cancer Res Treat; 1993; 25(3):203-10. PubMed ID: 8369521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term prognostic value of growth fraction determination by Ki-67 immunostaining in primary operable breast cancer.
    Pierga JY; Leroyer A; Viehl P; Mosseri V; Chevillard S; Magdelénat H
    Breast Cancer Res Treat; 1996; 37(1):57-64. PubMed ID: 8750528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.